Researchers from the MPI of Biochemistry and the Technical University of Munich have discovered new diagnostic markers for multiple sclerosis (MS), a disease that affects 3 million people worldwide.
pTau217, also called phosphorylated tau at threonine 217, is a specific blood-based biomarker for brain amyloid β pathology. When validated against CSF Aβ42/40 and PET imaging, the biomarker showed ...
Cerebrospinal fluid (CSF) biomarkers have become indispensable tools in the diagnosis, monitoring and mechanistic understanding of neurodegenerative diseases. By analysing proteins, peptides and other ...